Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 13,4x - 14,8x | 14,1x |
| Selected Fwd EBIT Multiple | 7,7x - 8,5x | 8,1x |
| Fair Value | 31,85₺ - 37,86₺ | 34,85₺ |
| Upside | -9,4% - 7,7% | -0,9% |
| Benchmarks | Ticker | Full Ticker |
| Aksu Enerji ve Ticaret Anonim Sirketi | AKSUE | IBSE:AKSUE |
| Aydem Yenilenebilir Enerji A.S. | AYDEM | IBSE:AYDEM |
| Consus Enerji Isletmeciligi ve Hizmetleri A.S. | CONSE | IBSE:CONSE |
| Biotrend Cevre ve Enerji Yatirimlari A.S. | BIOEN | IBSE:BIOEN |
| Kartal Yenilenebilir Enerji Uretim A.S. | KARYE | IBSE:KARYE |
| Aksa Enerji Üretim A.S. | AKSEN | IBSE:AKSEN |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| AKSUE | AYDEM | CONSE | BIOEN | KARYE | AKSEN | ||
| IBSE:AKSUE | IBSE:AYDEM | IBSE:CONSE | IBSE:BIOEN | IBSE:KARYE | IBSE:AKSEN | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | -20.8% | 8.4% | NM- | NM- | 49.7% | 40.7% | |
| 3Y CAGR | -36.7% | 31.8% | -17.4% | NM- | 84.0% | 41.4% | |
| Latest Twelve Months | -87.5% | -66.3% | 116.8% | -715.2% | 218.6% | -43.2% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 41.2% | 43.1% | -3.3% | 10.7% | 41.3% | 15.2% | |
| Prior Fiscal Year | 23.5% | 32.4% | -20.0% | 1.9% | 18.3% | 18.5% | |
| Latest Fiscal Year | 3.5% | 15.3% | 4.2% | -13.7% | 39.3% | 16.9% | |
| Latest Twelve Months | 3.5% | 15.3% | 4.2% | -13.7% | 39.3% | 16.9% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 10.71x | 5.34x | 2.90x | 4.71x | 4.97x | 2.34x | |
| EV / LTM EBITDA | 49.1x | 8.9x | 12.0x | 50.3x | 7.4x | 10.1x | |
| EV / LTM EBIT | 308.5x | 35.0x | 69.3x | -34.5x | 12.7x | 13.9x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -34.5x | 35.0x | 308.5x | ||||
| Historical EV / LTM EBIT | 3.8x | 10.2x | 13.9x | ||||
| Selected EV / LTM EBIT | 13.4x | 14.1x | 14.8x | ||||
| (x) LTM EBIT | 5,339 | 5,339 | 5,339 | ||||
| (=) Implied Enterprise Value | 71,713 | 75,487 | 79,262 | ||||
| (-) Non-shareholder Claims * | (30,990) | (30,990) | (30,990) | ||||
| (=) Equity Value | 40,723 | 44,498 | 48,272 | ||||
| (/) Shares Outstanding | 1,226.3 | 1,226.3 | 1,226.3 | ||||
| Implied Value Range | 33.21 | 36.28 | 39.36 | ||||
| FX Rate: TRY/TRY | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 33.21 | 36.28 | 39.36 | 35.16 | |||
| Upside / (Downside) | -5.6% | 3.2% | 12.0% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | AKSUE | AYDEM | CONSE | BIOEN | KARYE | AKSEN | |
| Enterprise Value | 668 | 35,166 | 3,965 | 12,670 | 1,925 | 74,108 | |
| (+) Cash & Short Term Investments | 31 | 2,603 | 27 | 99 | 55 | 1,057 | |
| (+) Investments & Other | 431 | 0 | 0 | 319 | 0 | 6 | |
| (-) Debt | (44) | (24,371) | (1,979) | (3,953) | (546) | (28,167) | |
| (-) Other Liabilities | 0 | 0 | 0 | (10) | 0 | (3,886) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 1,086 | 13,398 | 2,012 | 9,125 | 1,434 | 43,118 | |
| (/) Shares Outstanding | 66.0 | 698.9 | 771.0 | 500.0 | 55.0 | 1,226.3 | |
| Implied Stock Price | 16.45 | 19.17 | 2.61 | 18.25 | 26.08 | 35.16 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 16.45 | 19.17 | 2.61 | 18.25 | 26.08 | 35.16 | |
| Trading Currency | TRY | TRY | TRY | TRY | TRY | TRY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |